The exit you want in 2 to 5 years is being built, or broken, in the P&L you're running today.
Buyers don’t pay for a great final year. They pay for two to three years of clean, documented, growing EBITDA. That means the window that decides your sale price already started, whether you’ve made the decision to sell or not.
An extra $250,000 this year is not worth $250,000 at sale. It's worth four to eight times that.
Treatment centers don’t sell for a lump sum of income. They sell for a multiple of Adjusted EBITDA, meaning net income plus depreciation, amortization, interest, and legitimate owner add backs. That multiple is where the real leverage lives, and most owners have never seen it laid out in dollars.
Illustrative only. Your actual multiple depends on license type, size, payer mix, growth trend, and management depth.
Residential programs with strong commercial payer mix and accreditation tend to sit toward the higher end of typical ranges; PHP or IOP only operations and less diversified payer mixes tend to sit lower. Every facility is different, which is exactly why a real valuation matters more than a rule of thumb.
The flip side matters just as much. The same math runs in reverse. A facility that lets EBITDA slide by $250,000, through lost census, a bloated cost structure, or simply not tracking add backs, isn’t just down $250,000. It’s down $1,000,000 to $2,000,000 in what a buyer will pay. Nothing else in the business moves the needle this hard, this fast.
Why "I'm not selling yet" is the Wrong Reason to Wait
Buyers judge you on the trailing two to three years, not the year you finally decide to sell.
If you plan to sell in 2028 or 2030, the financials a buyer will scrutinize then are the ones you’re producing right now, in 2026 and 2027. An owner who starts cleaning up the books, documenting add backs, and fixing profitability the year they list will show up with one clean year of history behind them. Buyers discount hard for that, when they don’t walk away first.
Planning to sell and preparing to sell are two different clocks, and the second one needs a two to three year head start on the first.
What Buyers Actually Scrutinize
Five things that move your multiple, up or down
Documentation and add backs
If a buyer’s accountant can’t trace an add back to a bank statement, it doesn’t count. Undocumented owner perks and personal expenses buried in the P&L usually just get erased from EBITDA, not credited to you.
Referral source concentration
If one marketing partner, one call center, or one referral source drives a large share of admissions, buyers see a business that could lose a third of its census the day that relationship ends.
Payer mix
A strong, diversified commercial payer mix supports a higher multiple than a Medicaid heavy or single payer book, because it’s viewed as more durable and less exposed to reimbursement changes.
Owner dependency
A facility that runs on the owner’s relationships, clinical judgment, and daily presence is harder to finance and harder to sell. Buyers are purchasing a business, not a job that happens to include real estate.
Licensure, accreditation, and compliance standing
Current, clean licensure and accreditation (JCAHO, CARF, LegitScript) signal a transferable, bankable business. Lapses, open complaints, or unresolved compliance issues can stall or kill a deal in due diligence.
Start This Quarter, Not the Quarter You List
Five moves that pay off whether you sell in two years or ten
- Get a real opinion of value now, so you have a baseline to measure progress against instead of a guess.
- Start a written add back log this month. Every personal or one time expense, dated and documented, as it happens, not reconstructed later from memory.
- Pull your referral sources for the last 12 months and calculate what percentage comes from your single largest source.
- Identify one manager or clinical lead who could run daily operations for two weeks without you, and start building toward that.
- Confirm every license and accreditation is current, and resolve any open compliance items before a buyer’s due diligence team finds them first.
Find out where you actually stand
This page is for general planning and educational purposes only and is not a certified business appraisal, tax, or legal advice.
